H Kutsumi Selected Research

Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)

5/2010

Vitamin K3 attenuates lipopolysaccharide-induced acute lung injury through inhibition of nuclear factor-kappaB activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H Kutsumi Research Topics

Disease

2	Hemorrhage 10/2010 - 01/2008
1	Pathologic Constriction (Stenosis) 01/2018
1	Acute Lung Injury 05/2010
1	Inflammation (Inflammations) 05/2010
1	Necrosis 05/2010
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2010
1	Lung Injury 05/2010
1	Infections 01/2003
1	Peptic Ulcer (Peptic Ulcers) 01/2003

Drug/Important Bio-Agent (IBA)

1	LipopolysaccharidesIBA 05/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010
1	VitaminsIBA 05/2010
1	NF-kappa B (NF-kB)IBA 05/2010
1	Vitamin K 3 (Menadione)FDA Link 05/2010
1	Cytochrome P-450 CYP2C19IBA 01/2003
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2003
1	Proton Pump InhibitorsIBA 01/2003
1	Lansoprazole (Prevacid)FDA LinkGeneric 01/2003
1	Rabeprazole (Aciphex)FDA Link 01/2003
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2003

Therapy/Procedure

2	Surgical Instruments (Clip) 01/2018 - 10/2010
1	Blood Transfusion (Blood Transfusions) 01/2008